May 27, 2024


Ritsumeikan University


– New Collaboration Aimed at Advanced Talent Development-


CMIC HOLDINGS Co., Ltd. (Headquarters: Minato-ku, Tokyo; CEO: Kazuo Nakamura), which aims to realize a healthy society, and Ritsumeikan University College of Pharmaceutical Sciences (Kusatsu City, Shiga Prefecture; Dean: Ryo Kitahara) signed an agreement on collaboration and cooperation in education and research on Friday, May 24th.

This initiative was reached as a result of the shared desire of CMIC HOLDINGS, which wants to create opportunities for the continuous development of the pharmaceutical development industry both in Japan and overseas and for the training of human resources to achieve this, and Ritsumeikan University College of Pharmaceutical Sciences, which wants to develop more practical education to train students who can lead the future of medical care and pharmaceutical development with a global perspective.

Through this collaboration and agreement, we aim to improve research and education by actively exchanging each other’s knowledge, educational environment, and human resources. We also hope to promote collaboration related to internships. Through internships, students will be able to acquire advanced expertise in the fields of medical care and drug discovery while coming into contact with CMIC HOLDINGS’ cutting-edge technology and know-how. Through continued collaboration, the two organizations aim to further improve the quality of education and research, cultivate excellent professionals who will lead the fields of future medicine and drug discovery, and contribute to society.

■Initiatives based on the Collaboration Agreement: (1) Personnel exchanges for the purpose of educational and research activities; (2) Holding events such as lectures and seminars; (3) Joint research; (4) Dissemination and utilization of research results; and (5) Other matters deemed necessary to achieve this agreement.

Photo: Akihisa Mitake, Corporate Director, CMIC Holdings, and Ryo Kitahara, Dean of the Faculty of Pharmaceutical Sciences, Ritsumeikan University

Akihisa Mitake, Corporate Director, CMIC Holdings, and Ryo Kitahara, Dean of the Faculty of Pharmaceutical Sciences, Ritsumeikan University

■Comment from Ryo Kitahara, Dean of the Faculty of Pharmaceutical Sciences, Ritsumeikan University

“According to the Ministry of Health, Labor and Welfare, the average turnover rate of new employees within three years is in the early 30% range, and it is desirable for students to have the opportunity to proactively think about their future career choices and career development at university. Many pharmacy students are highly interested in jobs related to pharmaceutical development, but there are not many opportunities to learn about the various occupations and the qualities and abilities required for each.

Through this industry-academia collaboration, we have added a “Career Seminar in Pharmacy” subject to the Faculty of Pharmaceutical Sciences curriculum. This provides an opportunity for students to visit a company for several days and learn about pharmaceutical development in a practical environment while interacting with people from various occupations. By understanding the qualities and abilities required of pharmacy graduates from an early stage, we can expect to increase their motivation to learn and their interest in career development. We would like to support students so that they can develop a satisfying career after graduation.”


■Comment from Akihisa Mitake, Corporate Director, Director of Clinical CRO Business (Clinical CRO), CMIC Holdings Co., Ltd.

“Since our founding, we have been cultivating human resources who contribute to medical care through pharmaceutical development.

In recent years, we have also been cultivating healthcare human resources, and in cultivating a wide range of human resources, we are promoting the creation of a new business model that pursues evidence by engaging in human resource exchanges and joint research with academia.

We believe that this agreement on collaboration and cooperation with Ritsumeikan University will not be the traditional form of employment from the university to a company, but will be a program to cultivate human resources who can contribute to practical research to create new business models in the future, from among the human resource development aimed at “drug discovery,” which is Ritsumeikan University’s strength.”


■About the Ritsumeikan University College of Pharmaceutical Sciences

The Ritsumeikan University College of Pharmaceutical Sciences was established in 2008 at the Biwako-Kusatsu Campus in order to cultivate talent who can develop the potential of pharmacy and further enhance the value of pharmacy itself. In order to cultivate talent who can play an active role in society as pharmacology experts by studying three categories, “creating medicine,” “understanding the action of medicine,” and “using medicine correctly,” in line with their future career paths, the College offers a 6-year Department of Pharmacy and a 4-year Department of Pharmaceutical Sciences. As new medical

treatments such as regenerative medicine and gene therapy increase, the College offers distinctive education with the aim of cultivating talent who can contribute to the health and happiness of humanity and play an active role globally with a global perspective. For more information, please visit the website.


■About CMIC Group

CMIC was the first company in Japan to start a CRO (Clinical Research Organization) business in 1992, and now provides comprehensive pharmaceutical support services from development to manufacturing, sales and marketing. We also support overseas pharmaceutical, biotechnology and medical device companies entering the Japanese market, conducting clinical trials in Asia, and supporting pharmaceutical development and manufacturing in the United States and Japan. CMIC also provides new healthcare solutions to support individuals and local governments, and aims to develop a business model called PHVC (“Personal Health Value Creator”) that “maximizes the health value of each individual” based on our extensive experience and track record in fully supporting the value chain of pharmaceutical companies. The CMIC Group has more than 7,500 employees and 28 group companies worldwide. For more information, please visit our website.